US Patent 8013018 Aminoindane derivative or salt thereof
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+254 characters)
Article
Patent abstract
Provided is a compound that is an NMDA receptor antagonist having a broader safety margin, and is useful as an agent for treating or preventing Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, ischemic apoplexy, or pain.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Daisuke Suzuki0
Hiroaki Hoshii0
Junya Ohmori0
Kazushi Watanabe0
Nobuyuki Shiraishi0
Satoshi Hayashibe0
Shingo Yamasaki0
Takatoshi Kanayama0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08013018 Aminoindane derivative or salt thereof US Patent 8013018 Aminoindane derivative or salt thereof
Infobox
Patent Number
08013018
Patent Number
8013018
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08013018 Aminoindane derivative or salt thereof
Infobox
Is a
Patent jurisdiction
Patent number
08013018
Date of patent
September 6, 2011
Patent application number
12305254
Date Filed
July 17, 2007
Patent primary examiner
Find more entities like US Patent 8013018 Aminoindane derivative or salt thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
